Trial intelligence / Profile preview

Modafinil in Methamphetamine Dependence

NCT00751023Phase 4Completed

Sponsor
Medical University of South Carolina
Start
Feb 2009
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of modafinil in methamphetamine use disorder (MUD), sponsored by Medical University of South Carolina. Primary endpoint: Percentage of Participants With Methamphetamine-positive Urine Drug Screens at 5 weeks. Started Feb 2009; status: completed.

02

Drugs

modafinil
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on NCT00751023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00751023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call